AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 NOV 12 - (NewsRx.com & NewsRx.net) -- Human T-cells recognize N-terminally Fmoc-modified peptide.
According to a study from Australia, "We aimed to generate T-cell clones specific for human pre-proinsulin. An HLA DQ8, CD4+ T-cell clone that recognized a 10mer (C65-A9) peptide from pre-proinsulin was isolated. Further analysis revealed that the clone responded neither to recombinant proinsulin nor to re-synthesized C65-A9 peptide."
"Analysis of the original peptide revealed minor contamination (
Mannering and his coauthors published the results of their research in Vaccine (Human T-cells recognize N-terminally Fmoc-modified peptide. Vaccine, 2003;21(25-26):3638-3646).
For additional information, contact Stuart I. Mannering, Autoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, 1G Royal Parade, Parkville, Vic. 3050, ...
Source: HighBeam Research, Human T-cells recognize N-terminally Fmoc-modified peptide.